The Evolution and Sustainability of Diversity & Inclusion in Clinical Trials
In a new two- part executive brief series from H1, we explore:
- The role of social determinants of health in building diversity and equity into trials
- The critical role that trust plays in patient access and ensuring inclusive and equitable trials for drug development
